Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Citation: Breast Cancer Research & Treatment. 193(3):565, 2022 Jun.PMID: 35507135Department: Associate Dean for Research Development | MedStar HealthForm of publication: Journal ArticleMedline article type(s): Published ErratumYear: 2022Local holdings: Available online from MWHC library: 1997 - presentISSN:- 0167-6806
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 35507135 | Available | 35507135 |
Available online from MWHC library: 1997 - present
English